Find clinical trials for Triple Negative Breast Cancer in Portland, OR
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Portland, OR, USA:
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Portland, Oregon, United States and 216 other locations
immunologic activity of pembrolizumab plus chemotherapy when combined with various immunotherapy induction regimens as neoadjuvant therapy for triple...
Phase 2
Portland, Oregon, United States
(weekly paclitaxel or capecitabine) in unresectable/metastatic triple negative breast cancer (MTNBC) patients....
Phase 1, Phase 2
Portland, Oregon, United States and 1 other location
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Portland, Oregon, United States and 288 other locations
Event Free Survival (EFS), in women with residual hormone receptor negative, HER2-negative ("triple negative") re ...
Phase 2
Portland, Oregon, United States and 3 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...
Phase 3
Portland, Oregon, United States and 506 other locations
Researchers are looking for new ways to treat triple-negative breast cancer (TNBC) and hormone receptor (HR) low ...
Phase 2
Tigard, Oregon, United States and 16 other locations
pharmacokinetics, pharmacodynamics, maximum tolerated dose, and anti-tumor effects of AVZO-021 in patients with advanced solid tumors...
Phase 1, Phase 2
Portland, Oregon, United States and 12 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Portland, Oregon, United States and 275 other locations
to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received n...
Phase 3
Portland, Oregon, United States and 279 other locations
Clinical trials
Research sites
Resources
Legal